Viewing Study NCT03380260


Ignite Creation Date: 2025-12-25 @ 2:12 AM
Ignite Modification Date: 2026-01-07 @ 3:51 PM
Study NCT ID: NCT03380260
Status: COMPLETED
Last Update Posted: 2021-04-28
First Post: 2017-12-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Investigating Neural Processing of Social Stimuli
Sponsor: The University of Texas at Dallas
Organization:

Study Overview

Official Title: Investigating Neural Processing of Social Stimuli: Investigating a Neurobehavioral Mechanism of Paranoia
Status: COMPLETED
Status Verified Date: 2021-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The primary goal of the present study is to test whether neural activity in brain regions associated with processing threat and social stimuli may underlie paranoid thinking.
Detailed Description: Paranoia is a prominent symptom of psychosis that occurs in several other diagnoses, as well as the general population, and that is associated with significant distress and impairment. Previous research suggests that increased baseline activity of the amygdala and related neural circuits may serve as a mechanism for paranoid ideation. This exploratory study will use a paranoia induction procedure in healthy individuals who vary in pre-existing levels of paranoid ideation to test whether increases in self-reported paranoia are accompanied by increases in resting cerebral blood flow (CBF), decreased stimulus-driven neural activity in social processing networks, and increased behavioral perceptions of untrustworthiness.

Participants will be randomly assigned to participate in a paranoia induction procedure or a control condition and will then complete neuroimaging and behavioral assessments.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: